Nikkuni O, Kaira K, Toyoda M, Shino M, Sakakura K, Takahashi K, Tominaga H, Oriuchi N, Suzuki M, Iijima M, Asao T, Nishiyama M, Nagamori S, Kanai Y, Oyama T, Chikamatsu K
Compared to another common class of kidney medications, called DPP4is, GLP1-RA medications did better in helping slow the progression of kidney disease, keeping kidney disease patients out of the hospital and helping them survive
It is a once-weekly prescription medication administered via subcutaneous injection
The answer lies in a chain of indirect mechanisms that, when you trace them carefully, create a plausible pathway from your weekly injection to a urinary tract infection